524322 KABRADG

Kabra Drugs Share Price

 

 

Start SIP in KABRADG

Start SIP

Performance

  • Low
  • ₹28
  • High
  • ₹29
  • 52 Week Low
  • ₹10
  • 52 Week High
  • ₹33
  • Open Price₹29
  • Previous Close₹29
  • Volume63,145
  • 50 DMA₹26.76
  • 100 DMA₹23.63
  • 200 DMA₹19.09

Investment Returns

  • Over 1 Month -2.59%
  • Over 3 Month + 48.16%
  • Over 6 Month + 35.9%
  • Over 1 Year + 180.72%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 56.1
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 67
  • P/B Ratio
  • 2.6
  • Average True Range
  • 1.7
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.89
  • RSI
  • 47.81
  • MFI
  • 69.93

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹28.24
-0.37 (-1.29%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹28.82
  • 50 Day
  • ₹26.76
  • 100 Day
  • ₹23.63
  • 200 Day
  • ₹19.09

Resistance and Support

28.3 Pivot Speed
  • R3 30.08
  • R2 29.59
  • R1 28.79
  • S1 27.50
  • S2 27.01
  • S3 26.21

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results
2025-10-08 Others Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.
2025-09-02 Others Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.
2025-08-14 Quarterly Results

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
95%
5%

About Kabra Drugs

  • NSE Symbol
  • KABRADG
  • BSE Symbol
  • 524322
  • Managing Director
  • Mr. N Aravind
  • ISIN
  • INE323K01017

Similar Stocks to Kabra Drugs

Kabra Drugs FAQs

Kabra Drugs share price is ₹28 As on 11 January, 2026 | 20:13

The Market Cap of Kabra Drugs is ₹67 Cr As on 11 January, 2026 | 20:13

The P/E ratio of Kabra Drugs is 56.1 As on 11 January, 2026 | 20:13

The PB ratio of Kabra Drugs is 2.6 As on 11 January, 2026 | 20:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23